Cargando…

Depression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease

OBJECTIVE: Anxiety and depression have a negative influence in the quality of life. The aim of the study was to determinate the levels of sensitivity and specificity of the Anxiety and Hospital Depression Scale (HADS) and compare the quality of life in patients with inflammatory bowel disease (IBD)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto-Furusho, Jesús K., Bozada Gutiérrez, Katya E., Sarmiento-Aguilar, Andrea, Fresán-Orellana, Ana, Arguelles-Castro, Perla, García-Alanis, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566083/ https://www.ncbi.nlm.nih.gov/pubmed/34746297 http://dx.doi.org/10.1155/2021/5540786

Ejemplares similares

Mortality and Hospitalizations in Mexican Patients with Inflammatory Bowel Disease: Results from a Nationwide Health Registry
por: Sarmiento-Aguilar, Andrea, et al.
Publicado: (2020)

Incidence and prevalence of inflammatory bowel disease in Mexico from a nationwide cohort study in a period of 15 years (2000–2017)
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2019)

Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies
por: Yamamoto-Furusho, Jesús K
Publicado: (2017)

Emerging therapeutic options in inflammatory bowel disease
por: Yamamoto-Furusho, Jesus K, et al.
Publicado: (2021)

Caspase recruitment domain (CARD) family (CARD9, CARD10, CARD11, CARD14 and CARD15) are increased during active inflammation in patients with inflammatory bowel disease
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2018)

Diagnostic Delay of Inflammatory Bowel Disease Is Significantly Higher in Public versus Private Health Care System in Mexican Patients
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2021)

Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease
por: Byrne, Glynis, et al.
Publicado: (2017)

Depression and Anxiety Disorders in Patients With Inflammatory Bowel Disease
por: Hu, Shurong, et al.
Publicado: (2021)

Indoleamine 2,3-Dioxygenase: Expressing Cells in Inflammatory Bowel Disease—A Cross-Sectional Study
por: Furuzawa-Carballeda, Janette, et al.
Publicado: (2013)

Anxiety, Depression, and Quality of Life in Parents of Adolescents with Inflammatory Bowel Disease: A Longitudinal Study
por: Nomura, Satomi, et al.
Publicado: (2023)

Comment on “Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease”
por: Lai, Wenwen, et al.
Publicado: (2018)

Growth Factors as Treatment for Inflammatory Bowel Disease: A Concise Review of the Evidence Toward Their Potential Clinical Utility
por: Barahona-Garrido, Josué, et al.
Publicado: (2009)

The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease
por: Yanartas, O, et al.
Publicado: (2016)

Anxiety and depression in patients with inactive inflammatory bowel disease: The role of fatigue and health-related quality of life
por: Stroie, Tudor, et al.
Publicado: (2023)

Differential Expression of IL-36 Family Members and IL-38 by Immune and Nonimmune Cells in Patients with Active Inflammatory Bowel Disease
por: Fonseca-Camarillo, Gabriela, et al.
Publicado: (2018)

Aspects of inflammatory bowel disease during the COVID-19 pandemic and general considerations()
por: de León-Rendón, J.L., et al.
Publicado: (2020)

Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease
por: Fiest, Kirsten M., et al.
Publicado: (2016)

Symptoms of anxiety/depression is associated with more aggressive inflammatory bowel disease
por: Gao, Xin, et al.
Publicado: (2021)

2375. Association Between Clostridium difficile Colonization and Inflammatory Bowel Disease Activity
por: Morado-Aramburo, Oscar, et al.
Publicado: (2019)

Factors Associated with Anxiety and Depression in Korean Patients with Inactive Inflammatory Bowel Disease
por: Kim, Min Chul, et al.
Publicado: (2016)

Clinical and Translational Considerations for Understanding Depression and Anxiety in Patients with Inflammatory Bowel Disease
por: Sidebottom, Ashley M., et al.
Publicado: (2021)

Depressive and Anxiety Disorders in Patients with Inflammatory Bowel Diseases: Are There Any Gender Differences?
por: Fracas, Elia, et al.
Publicado: (2023)

Correlation Analysis Between Disease Activity and Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Inflammatory Bowel Disease
por: Yu, Rong, et al.
Publicado: (2023)

Anxiety and Depression in Irritable Bowel Syndrome
por: Banerjee, Arko, et al.
Publicado: (2017)

Depressive Symptoms and Quality of Life in the Patients of Inflammatory Bowel Disease
por: Lee, Jung Won
Publicado: (2017)

Anxiety and Depression in Patients with Inflammatory Bowel Diseases: The First Step toward Proper Management
por: Lee, Jung Won
Publicado: (2020)

Assessment of Comorbid Depression and Anxiety in Inflammatory Bowel Disease Using Adaptive Testing Technology
por: Karpin, Jordan E, et al.
Publicado: (2021)

Surgical treatment of acute cholecystitis in patients with confirmed COVID-19: Ten case reports and review of literature
por: Bozada-Gutiérrez, Katya, et al.
Publicado: (2022)

Risk of Anxiety and Depression in Patients with Inflammatory Bowel Disease: A Nationwide, Population-Based Study
por: Choi, Kookhwan, et al.
Publicado: (2019)

Depression, Anxiety, Related Risk Factors and Cognitive Distortion in Korean Patients with Inflammatory Bowel Disease
por: Song, Jun Ho, et al.
Publicado: (2020)

Anxiety and Depression in Patients With Inflammatory Bowel Disease at King Fahad Specialist Hospital, Qassim Region
por: Alnafisah, Khaled, et al.
Publicado: (2023)

Symptoms of anxiety and depression associated with steroid efficacy and clinical outcomes in patients with inflammatory bowel disease
por: Duan, Shihao, et al.
Publicado: (2023)

Fatigue Is Associated with Anxiety and Lower Health-Related Quality of Life in Patients with Inflammatory Bowel Disease in Remission
por: Stroie, Tudor, et al.
Publicado: (2023)

Non-pharmacological Interventions for Anxiety and Depression in Adults With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
por: Davis, Suja P., et al.
Publicado: (2020)

Prevalence of depression and anxiety in people with inflammatory bowel disease and associated healthcare use: population-based cohort study
por: Irving, Peter, et al.
Publicado: (2021)

Longitudinal trajectories of anxiety, depression, and bipolar disorder in inflammatory bowel disease: a population-based cohort study
por: Bisgaard, Tania H., et al.
Publicado: (2023)

Pain in Patients with Dystrophic Epidermolysis Bullosa: Association with Anxiety and Depression
por: Fortuna, Giulio, et al.
Publicado: (2017)

Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey
por: Bernstein, Charles N, et al.
Publicado: (2020)

Depression and anxiety associated with functional bowel disorders and its impact on quality of life: A cross-sectional study
por: Sarkar, Sukanto, et al.
Publicado: (2020)

Inflammatory bowel disease and anxiety: links, risks, and challenges faced
por: Bannaga, Ayman S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fk4r3fh6pknnr5ocgi2co7iivp